TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Work Place Adjusted Intelligent Physical Exercise Reducing Musculoskeletal Pain in Shoulder and Neck (VIMS, Danish Acronym)
Brief Summary: Musculoskeletal disorders are frequent among office workers especially in the neck/shoulder area.

The hypothesis is, that specific strength training of the neck/shoulder muscles will alleviate the pain.

The two sub-hypotheses are

1. Alleviation of pain is independent of training frequency
2. Alleviation of pain is higher following supervised training vs training with initial instruction only


Options:
A: Arm Label: 1; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Other: spinal manipulation | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Other: Spinal manipulation + exercises | Intervention Type: OTHER; Name: spinal manipulation; Assigned to Arm(s): 2 | Intervention Type: OTHER; Name: Spinal manipulation + exercises; Assigned to Arm(s): 3
B: Arm Label: wait and see; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: collar; Type: EXPERIMENTAL; Interventions: Other: cervical collar | Arm Label: physiotherapy; Type: EXPERIMENTAL; Interventions: Other: physiotherapy | Intervention Type: OTHER; Name: cervical collar; Assigned to Arm(s): collar | Intervention Type: OTHER; Name: physiotherapy; Assigned to Arm(s): physiotherapy
C: Arm Label: Specific resistance training; Type: ACTIVE_COMPARATOR; Interventions: Other: Work Place Adjusted Intelligent Physical Exercise Reducing Musculoskeletal Pain in Shoulder and Neck | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Work Place Adjusted Intelligent Physical Exercise Reducing Musculoskeletal Pain in Shoulder and Neck; Assigned to Arm(s): Specific resistance training
D: Arm Label: 1 hr training 50% supervision; Type: EXPERIMENTAL; Interventions: Behavioral: physical training exercise | Arm Label: 3 x 20 min training 50% supervision; Type: EXPERIMENTAL; Interventions: Behavioral: physical training exercise | Arm Label: 3 x 20 min training initial instructions; Type: EXPERIMENTAL; Interventions: Behavioral: physical training exercise | Arm Label: 10 x 6 min training 50% supervision; Type: EXPERIMENTAL; Interventions: Behavioral: physical training exercise | Arm Label: reference; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: physical training exercise; Assigned to Arm(s): 1 hr training 50% supervision, 10 x 6 min training 50% supervision, 3 x 20 min training 50% supervision, 3 x 20 min training initial instructions

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Simplified Antibiotic Regimens for the Management of Sepsis in Young Infants in First-level Facilities: Randomized Controlled Trial
Brief Summary: This trial evaluates primary care clinic-based simplified antibiotic therapy options for young infants, 0-59 days old in high neonatal mortality settings in peri-urban Karachi where hospital referral is frequently refused by families.


Options:
A: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Health Education & Promotion, Other: Training of Health Workers, Behavioral: Community Mobilization | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Health Education & Promotion; Assigned to Arm(s): Intervention | Intervention Type: OTHER; Name: Training of Health Workers; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Community Mobilization; Assigned to Arm(s): Intervention
B: Arm Label: Experimental; Type: EXPERIMENTAL; Interventions: Behavioral: Training HC/VHSG, Health Education, and Supportive Supervision | Arm Label: No Intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Training HC/VHSG, Health Education, and Supportive Supervision; Assigned to Arm(s): Experimental
C: Arm Label: procaine penicillin and gentamicin; Type: ACTIVE_COMPARATOR; Interventions: Drug: procaine penicillin and gentamicin, Drug: procaine penicillin, gentamicin, amoxicillin | Arm Label: Amoxicillin and gentamicin; Type: EXPERIMENTAL; Interventions: Drug: amoxicillin and gentamicin, Drug: procaine penicillin, gentamicin, amoxicillin | Arm Label: procaine penicillin, gentamicin, and amoxicillin; Type: EXPERIMENTAL; Interventions: Drug: procaine penicillin, gentamicin, amoxicillin | Intervention Type: DRUG; Name: procaine penicillin and gentamicin; Assigned to Arm(s): procaine penicillin and gentamicin | Intervention Type: DRUG; Name: amoxicillin and gentamicin; Assigned to Arm(s): Amoxicillin and gentamicin | Intervention Type: DRUG; Name: procaine penicillin, gentamicin, amoxicillin; Assigned to Arm(s): Amoxicillin and gentamicin, procaine penicillin and gentamicin, procaine penicillin, gentamicin, and amoxicillin
D: Arm Label: Neonatal Kit; Type: EXPERIMENTAL; Interventions: Device: Neonatal Kit | Arm Label: Neonatal Stimulation; Type: EXPERIMENTAL; Interventions: Behavioral: Neonatal Stimulation | Arm Label: Neonatal Kit and Neonatal Stimulation; Type: EXPERIMENTAL; Interventions: Device: Neonatal Kit, Behavioral: Neonatal Stimulation | Arm Label: Control (Standard Care); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Neonatal Kit; Assigned to Arm(s): Neonatal Kit, Neonatal Kit and Neonatal Stimulation | Intervention Type: BEHAVIORAL; Name: Neonatal Stimulation; Assigned to Arm(s): Neonatal Kit and Neonatal Stimulation, Neonatal Stimulation

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Simplified Antibiotic Regimens for the Management of Sepsis in Young Infants in First-level Facilities: Randomized Controlled Trial
Brief Summary: This trial evaluates primary care clinic-based simplified antibiotic therapy options for young infants, 0-59 days old in high neonatal mortality settings in peri-urban Karachi where hospital referral is frequently refused by families.


Options:
A: Intervention Type: BEHAVIORAL; Name: Improved management of severe neonatal infections; Assigned to Arm(s): N/A
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Gentamicin & Amoxicillin x 7days | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Penicillin & gentamicin x 2 d + Amoxicillin X 5 d | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Drug: Standard reference therapy | Intervention Type: DRUG; Name: Gentamicin & Amoxicillin x 7days; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Penicillin & gentamicin x 2 d + Amoxicillin X 5 d; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Standard reference therapy; Assigned to Arm(s): 3
C: Arm Label: Arm1; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Other: Community Based | Intervention Type: OTHER; Name: Community Based; Assigned to Arm(s): 2
D: Arm Label: procaine penicillin and gentamicin; Type: ACTIVE_COMPARATOR; Interventions: Drug: procaine penicillin and gentamicin, Drug: procaine penicillin, gentamicin, amoxicillin | Arm Label: Amoxicillin and gentamicin; Type: EXPERIMENTAL; Interventions: Drug: amoxicillin and gentamicin, Drug: procaine penicillin, gentamicin, amoxicillin | Arm Label: procaine penicillin, gentamicin, and amoxicillin; Type: EXPERIMENTAL; Interventions: Drug: procaine penicillin, gentamicin, amoxicillin | Intervention Type: DRUG; Name: procaine penicillin and gentamicin; Assigned to Arm(s): procaine penicillin and gentamicin | Intervention Type: DRUG; Name: amoxicillin and gentamicin; Assigned to Arm(s): Amoxicillin and gentamicin | Intervention Type: DRUG; Name: procaine penicillin, gentamicin, amoxicillin; Assigned to Arm(s): Amoxicillin and gentamicin, procaine penicillin and gentamicin, procaine penicillin, gentamicin, and amoxicillin

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Smoking Cessation Treatment for Methadone Maintenance Patients
Brief Summary: Patients in substance abuse treatment smoke four times more than non-substance abusers, and suffer high rates of tobacco-related disease and death. While many quit smoking treatments exist that have been shown to help non-substance abusers quit smoking, little is known about what treatments work for patients in substance abuse treatment. The drug varenicline (Chantix) has been shown to be more effective at helping people quit smoking than nicotine replacement therapy, bupropion or placebo. However, varenicline has not yet been studied in patients in substance abuse treatment. The study aims to evaluate the feasibility, effectiveness and safety of varenicline, in combination with counseling, in methadone maintained smokers. It also aims to evaluate the link between quitting smoking and alcohol and illicit drug use in methadone maintained smokers. We hypothesize that participants receiving varenicline will have higher abstinence from smoking than participants receiving placebo and that participants taking varenicline will not have significantly more adverse reactions than were described in the general population in other studies. We also hypothesize that compared to continued smokers, tobacco abstainers will be more likely to be abstinent from alcohol or illicit drugs.


Options:
A: Arm Label: Chantix (varenicline); Type: EXPERIMENTAL; Interventions: Drug: Chantix | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Chantix; Assigned to Arm(s): Chantix (varenicline) | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: varenicline; Type: EXPERIMENTAL; Interventions: Drug: Varenicline | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: Varenicline; Assigned to Arm(s): varenicline | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): placebo
C: Arm Label: Extended Run-In; Type: EXPERIMENTAL; Interventions: Drug: Varenicline, Behavioral: Brief smoking cessation counseling | Arm Label: Standard Run-In; Type: ACTIVE_COMPARATOR; Interventions: Drug: Varenicline, Behavioral: Brief smoking cessation counseling | Intervention Type: DRUG; Name: Varenicline; Assigned to Arm(s): Extended Run-In, Standard Run-In | Intervention Type: BEHAVIORAL; Name: Brief smoking cessation counseling; Assigned to Arm(s): Extended Run-In, Standard Run-In
D: Arm Label: Varenicline; Type: EXPERIMENTAL; Interventions: Drug: Varenicline | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Varenicline; Assigned to Arm(s): Varenicline | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Smoking Cessation Treatment for Methadone Maintenance Patients
Brief Summary: Patients in substance abuse treatment smoke four times more than non-substance abusers, and suffer high rates of tobacco-related disease and death. While many quit smoking treatments exist that have been shown to help non-substance abusers quit smoking, little is known about what treatments work for patients in substance abuse treatment. The drug varenicline (Chantix) has been shown to be more effective at helping people quit smoking than nicotine replacement therapy, bupropion or placebo. However, varenicline has not yet been studied in patients in substance abuse treatment. The study aims to evaluate the feasibility, effectiveness and safety of varenicline, in combination with counseling, in methadone maintained smokers. It also aims to evaluate the link between quitting smoking and alcohol and illicit drug use in methadone maintained smokers. We hypothesize that participants receiving varenicline will have higher abstinence from smoking than participants receiving placebo and that participants taking varenicline will not have significantly more adverse reactions than were described in the general population in other studies. We also hypothesize that compared to continued smokers, tobacco abstainers will be more likely to be abstinent from alcohol or illicit drugs.


Options:
A: Arm Label: Varenicline; Type: EXPERIMENTAL; Interventions: Drug: Varenicline | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Varenicline; Assigned to Arm(s): Varenicline | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Effectiveness of Nicotine patch only; Type: EXPERIMENTAL; Interventions: Drug: Nicotine Patch | Arm Label: Effectiveness of Combination NRT; Type: EXPERIMENTAL; Interventions: Drug: Nicotine lozenge, Drug: Nicotine Patch | Arm Label: Effectiveness of Varenicline [Chantix]; Type: EXPERIMENTAL; Interventions: Drug: Varenicline | Intervention Type: DRUG; Name: Varenicline; Assigned to Arm(s): Effectiveness of Varenicline [Chantix] | Intervention Type: DRUG; Name: Nicotine lozenge; Assigned to Arm(s): Effectiveness of Combination NRT | Intervention Type: DRUG; Name: Nicotine Patch; Assigned to Arm(s): Effectiveness of Combination NRT, Effectiveness of Nicotine patch only
C: Intervention Type: DRUG; Name: varenicline; Assigned to Arm(s): N/A
D: Arm Label: Varenicline; Type: ACTIVE_COMPARATOR; Interventions: Drug: Varenicline | Arm Label: Sugar Pill or Placebo; Type: ACTIVE_COMPARATOR; Interventions: Drug: Sugar pill or Placebo | Intervention Type: DRUG; Name: Varenicline; Assigned to Arm(s): Varenicline | Intervention Type: DRUG; Name: Sugar pill or Placebo; Assigned to Arm(s): Sugar Pill or Placebo

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Smoking Cessation Treatment for Methadone Maintenance Patients
Brief Summary: Patients in substance abuse treatment smoke four times more than non-substance abusers, and suffer high rates of tobacco-related disease and death. While many quit smoking treatments exist that have been shown to help non-substance abusers quit smoking, little is known about what treatments work for patients in substance abuse treatment. The drug varenicline (Chantix) has been shown to be more effective at helping people quit smoking than nicotine replacement therapy, bupropion or placebo. However, varenicline has not yet been studied in patients in substance abuse treatment. The study aims to evaluate the feasibility, effectiveness and safety of varenicline, in combination with counseling, in methadone maintained smokers. It also aims to evaluate the link between quitting smoking and alcohol and illicit drug use in methadone maintained smokers. We hypothesize that participants receiving varenicline will have higher abstinence from smoking than participants receiving placebo and that participants taking varenicline will not have significantly more adverse reactions than were described in the general population in other studies. We also hypothesize that compared to continued smokers, tobacco abstainers will be more likely to be abstinent from alcohol or illicit drugs.


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Varenicline; Type: EXPERIMENTAL; Interventions: Drug: Varenicline | Intervention Type: DRUG; Name: Varenicline; Assigned to Arm(s): Varenicline | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: cigarette substitute; Type: EXPERIMENTAL; Interventions: Other: cigarette substitute | Arm Label: e-cigarette (with 0 mg/ml nicotine); Type: EXPERIMENTAL; Interventions: Other: e-cigarette | Arm Label: e-cigarette (with 8 mg/ml nicotine); Type: EXPERIMENTAL; Interventions: Other: e-cigarette | Arm Label: e-cigarette (with 36 mg/ml nicotine); Type: EXPERIMENTAL; Interventions: Other: e-cigarette | Intervention Type: OTHER; Name: e-cigarette; Assigned to Arm(s): e-cigarette (with 0 mg/ml nicotine), e-cigarette (with 36 mg/ml nicotine), e-cigarette (with 8 mg/ml nicotine) | Intervention Type: OTHER; Name: cigarette substitute; Assigned to Arm(s): cigarette substitute
C: Arm Label: Varenicline; Type: EXPERIMENTAL; Interventions: Drug: Varenicline | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Varenicline; Assigned to Arm(s): Varenicline | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Champix | Intervention Type: DRUG; Name: Champix; Assigned to Arm(s): Placebo

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Smoking Cessation Treatment for Methadone Maintenance Patients
Brief Summary: Patients in substance abuse treatment smoke four times more than non-substance abusers, and suffer high rates of tobacco-related disease and death. While many quit smoking treatments exist that have been shown to help non-substance abusers quit smoking, little is known about what treatments work for patients in substance abuse treatment. The drug varenicline (Chantix) has been shown to be more effective at helping people quit smoking than nicotine replacement therapy, bupropion or placebo. However, varenicline has not yet been studied in patients in substance abuse treatment. The study aims to evaluate the feasibility, effectiveness and safety of varenicline, in combination with counseling, in methadone maintained smokers. It also aims to evaluate the link between quitting smoking and alcohol and illicit drug use in methadone maintained smokers. We hypothesize that participants receiving varenicline will have higher abstinence from smoking than participants receiving placebo and that participants taking varenicline will not have significantly more adverse reactions than were described in the general population in other studies. We also hypothesize that compared to continued smokers, tobacco abstainers will be more likely to be abstinent from alcohol or illicit drugs.


Options:
A: Arm Label: Varenicline Tartrate; Type: ACTIVE_COMPARATOR; Interventions: Drug: Varenicline Tartrate | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Varenicline Tartrate; Assigned to Arm(s): Varenicline Tartrate | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Varenicline; Type: EXPERIMENTAL; Interventions: Drug: Varenicline | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Varenicline; Assigned to Arm(s): Varenicline | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Intervention Type: DRUG; Name: varenicline (CP-526,555); Assigned to Arm(s): N/A
D: Arm Label: varenicline and buproprion SR; Type: ACTIVE_COMPARATOR; Interventions: Drug: Varenicline, Drug: bupropion SR | Arm Label: varenicline and placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Varenicline, Drug: placebo | Intervention Type: DRUG; Name: Varenicline; Assigned to Arm(s): varenicline and buproprion SR, varenicline and placebo | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): varenicline and placebo | Intervention Type: DRUG; Name: bupropion SR; Assigned to Arm(s): varenicline and buproprion SR

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Computer-Assisted Brief Motivational Intervention for Smoking During Pregnancy: The Healthy Pregnancy Project (HPP)
Brief Summary: This study will develop:

1. Develop the computer-based brief intervention and Contingency Management (CM) components, with repeated feedback from experts, prenatal clinic staff, and participants.
2. Recruit 110 pregnant women who are actively smoking, and randomly assign recruited women to Brief Intervention, CM, combined, or control conditions.
3. Conduct follow-up evaluation at 12 weeks post-intervention to measure self-reported smoking, breath carbon monoxide (CO), and urinary cotinine levels.
4. Collect data regarding birth outcomes and evaluate the feasibility of various methods of post-partum follow-up.


Options:
A: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Computerized brief intervention (5As); Type: EXPERIMENTAL; Interventions: Behavioral: Computer-delivered brief intervention (5As) | Arm Label: Contingency Management Alone; Type: EXPERIMENTAL; Interventions: Behavioral: Contingency Management | Arm Label: Combined Brief Intervention and CM; Type: EXPERIMENTAL; Interventions: Behavioral: Computer-delivered brief intervention (5As), Behavioral: Contingency Management | Intervention Type: BEHAVIORAL; Name: Computer-delivered brief intervention (5As); Assigned to Arm(s): Combined Brief Intervention and CM, Computerized brief intervention (5As) | Intervention Type: BEHAVIORAL; Name: Contingency Management; Assigned to Arm(s): Combined Brief Intervention and CM, Contingency Management Alone
B: Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Counseling from WTQL | Arm Label: Incentive; Type: EXPERIMENTAL; Interventions: Behavioral: Counseling from WTQL, Other: Financial incentive to participate | Intervention Type: BEHAVIORAL; Name: Counseling from WTQL; Assigned to Arm(s): Control, Incentive | Intervention Type: OTHER; Name: Financial incentive to participate; Assigned to Arm(s): Incentive
C: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Intervention | Arm Label: Enhanced Traditional Care control; Type: ACTIVE_COMPARATOR; Interventions: Other: Enhanced Traditional Care control | Intervention Type: BEHAVIORAL; Name: Intervention; Assigned to Arm(s): Intervention | Intervention Type: OTHER; Name: Enhanced Traditional Care control; Assigned to Arm(s): Enhanced Traditional Care control
D: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Brief smoking cessation counseling | Arm Label: B; Type: EXPERIMENTAL; Interventions: Behavioral: Contingency Management, Behavioral: Brief smoking cessation counseling | Intervention Type: BEHAVIORAL; Name: Contingency Management; Assigned to Arm(s): B | Intervention Type: BEHAVIORAL; Name: Brief smoking cessation counseling; Assigned to Arm(s): A, B

Answer: A